This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
My contract was terminated and the contracting officer did not pay my invoices – what can I do...
The course will explore new guidance concerning FCPA enforcement issued by the Trump Administration ...
This program provides attorneys with a practical examination of how legal, regulatory, and liability...
This program introduces psychosocial evaluations as a valuable tool in civil litigation, particularl...
This course will provide a detailed overview of the Medicare Secondary Payer act as well as provide ...
Adverse and derogatory information often has devastating effects on a contractor's ability to win co...
Use of artificial intelligence and other automated tools for performance and predictive analytics in...
Trademark doctrine was built for a marketplace that no longer exists, leaving practitioners to litig...
This program provides attorneys with a foundational understanding of derivatives and their role in m...
Most legal professionals are operating in survival mode whether they realize it or not. Not crisis-l...